Return To The Previous Page
Buy a Package
Number Of Visible Items Remaining : 3 Item

Rate of bleeding stratified by risk in patients with venous thromboembolism (VTE) on anticoagulation

Rate of bleeding stratified by risk in patients with venous thromboembolism (VTE) on anticoagulation
Bleeding risk First 3 months Annual rate after first 3 months
Low risk (no risk factors present) 1.6% 0.8%
Intermediate risk (one risk factor present) 3.2% 1.3%
High risk (two or more risk factors present) 12.8% ≥6.5%
Data from: Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141:e419S.
Graphic 107543 Version 2.0

Do you want to add Medilib to your home screen?